APR 22, 2017 1:59 PM PDT

Bacteria-infecting Viruses Inspire Creation of Hybrid Antibodies

WRITTEN BY: Kara Marker

It seems humans share a common enemy with some viruses: bacteria. Viruses invade bacterial cells with generally the same agenda that bacteria have when invading the human body - wipe out host cells and multiply. Borrowing a page from the playbook of bacteria-infecting viruses, called bacteriophages, could help researchers enhance the human immune system to better attack the toughest bacterial species.

Summoned by lysibody molecules, large immune cells called macrophages (red) engulf Staphylococcus aureus bacteria (green).

Bacteriophages have unique molecules that recognize and target specific carbohydrate molecules on the cell surface of bacteria, but the human immune system is ignorant of these molecules. “We have co-opted these molecules, and we've put them to work helping the human immune system fight off microbial pathogens," explained lab head Vincent A. Fischetti.

These viruses then use lysins, dubbed “molecular snippers” by Fischetti and his team, to poke holes in the cell surface of the bacterium after latching on to cell surface carbohydrate molecules. Antibodies produced by the human immune system are similar in structure and practice a similar method, but alas they are unable to identify bacterial carbohydrate molecules.

"Both antibodies and lysins have two discrete components,” explained research associate Assaf Raz. “They both have a part that binds their respective target, but whereas the second component of lysins cuts the bacterial cell wall, in antibodies it coordinates an immune response.”

In their study, researchers replaced the parts of human antibodies where their anti-bacterial approach fell short with the advantages of lysins, a switch made possible thanks to the two components sharing similar structure.

"This made it possible for us to mix and match, combining the viral piece responsible for latching onto a carbohydrate with the part of the antibody that tells immune cells how to respond,” Raz said.

The new “best of both worlds” antibody they created was labeled a lysibody, and the researchers ventured next to test lysibodies in a mice model of methicillin-resistant Staphylococcus aureus, commonly known as MRSA, a bacterial species infamous for being resistant to the harshest antibiotic treatments, earning the name of “superbug.”

The mice studies were successful; the experimental lysibodies identified and targeted carbohydrates on the cell surface of MRSA bacteria as well as other strains of S. aureus and even other types of bacteria.

“Based on our results, it may be possible to use not just lysins, but any molecule with a high affinity toward a target on any pathogen -- be it virus, parasite, or fungus -- to create hybrid antibodies," Fischetti claimed. "This approach could make it possible to develop a new class of immune boosting therapies for infectious diseases."

The present study was published in the journal Proceedings for the National Academy of Sciences.

Source: The Rockefeller University

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
NOV 09, 2021
Immunology
Wikipedia, but Make It Immune Cells
NOV 09, 2021
Wikipedia, but Make It Immune Cells
Scientists have established the first searchable database of complex immune data, providing the foundations for a new er ...
NOV 11, 2021
Immunology
Some Patients Left Vulnerable to COVID Even After Getting Vaccinated
NOV 11, 2021
Some Patients Left Vulnerable to COVID Even After Getting Vaccinated
Global vaccination efforts continue in the backdrop of the ongoing pandemic. However, new studies demonstrate how severa ...
NOV 11, 2021
Cell & Molecular Biology
Why Arthritis Tends to Affect the Same Joints Repeatedly
NOV 11, 2021
Why Arthritis Tends to Affect the Same Joints Repeatedly
While arthritis may not cause pain all the time, when it flares, it tends to recur in the same joints. This can create s ...
NOV 25, 2021
Immunology
Battling Bacterial Pneumonia, No Antibiotics Required
NOV 25, 2021
Battling Bacterial Pneumonia, No Antibiotics Required
Instead of flooding the body with antibiotics, what if we could program cells to fight off pathogens more effectively? T ...
DEC 06, 2021
Health & Medicine
Can Behavioral Science Strategies Improve Vaccination Rates?
DEC 06, 2021
Can Behavioral Science Strategies Improve Vaccination Rates?
Vaccines stimulate the immune system to defend us against serious infectious diseases. In addition, vaccination prevents ...
DEC 09, 2021
Cannabis Sciences
Considering Cannabinoids as a COVID-19 Treatment
DEC 09, 2021
Considering Cannabinoids as a COVID-19 Treatment
Research suggests that Cannabis sativa-derived cannabinoids – such as cannabidiol (CBD), Δ9tetrahydrocannabi ...
Loading Comments...